EWG Elevate’s VanEck Biotech ETF BBH Stock Holding History

EWG Elevate’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,371	Closed	-$363K	–	125
2025 Q2	$363K	Buy	+2,371	New	+$353K	0.11%	108

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BFG

Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.26B AUM 24.75% 1-Year Est. Return

EWG Elevate's BBH Position: Q3 2025 in Review

EWG Elevate sold out of VanEck Biotech ETF (BBH) in Q3 2025, closing a stake of 2,371 shares — an estimated $363K sold.

EWG Elevate first reported a position in BBH in Q2 2025 and held it in 1 quarter. The position peaked at $363K in Q2 2025. 106 funds tracked by Wall St. Rank hold BBH as of Q3 2025.

EWG Elevate reported no remaining VanEck Biotech ETF position as of Q3 2025 after selling out during the quarter.
EWG Elevate sold 2,371 VanEck Biotech ETF shares in Q3 2025, an estimated $363K.
EWG Elevate first reported a position in VanEck Biotech ETF in Q2 2025 and held it in 1 quarter.
EWG Elevate's VanEck Biotech ETF position peaked at $363K in Q2 2025.
106 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q3 2025.

Based on EWG Elevate's 13F filing for Q3 2025, filed 7 Oct 2025.